Effectiveness of @entity227 for convergence dysfunctions and long-term stability after XXXX .

@entity1 @entity227 @entity1887 @entity409 @entity1319
BACKGROUND: Symptomatic @entity1319 ( @entity1319 ) is a common @entity409 . It is often associated with @entity1887 ( @entity1887 ). Optimum therapy for this condition was recently shown to be in-clinic @entity227 ( @entity227 ). More scientific studies are needed to assess the effectiveness of @entity227 and verify these evidence-based results. METHODS: Fifty-seven @entity1 aged 9-13 years were diagnosed with symptomatic @entity1319 (n = 27) or combined symptomatic @entity1319 and @entity1887 (n = 30). They were independently divided into a treatment and a control group, matched by age and gender. The treatment group received 12 weeks of @entity227 while the control group received no therapy. A quality of life instrument documented the symptomatic @entity1 and charted improvement in symptoms after therapy. Clinical aspects were also assessed to determine the treatment effects on clinical findings. Twenty @entity1 in the treatment group completed a 1 year follow-up examination. RESULTS: Symptom scores and clinical measures of the treatment and control groups were not significantly different at baseline (p > 0.05), but showed significant differences after completion of 12 weeks of treatment (p < 0.001). No significant changes of either symptoms or signs were evident for the control group. One year follow-up examination revealed that most @entity1 maintained the improved symptom and clinical measures after @entity227 . CONCLUSION: This study supports the notion that @entity227 is a successful method of treating @entity1319 and @entity1319 combined with @entity1887 .
